The botulinum toxin market was valued at USD 13.2 billion in 2025 and is estimated at USD 14.4 billion in 2026. It is projected to reach USD 27.9 billion by 2033, a CAGR of 9.9% from 2026 to 2033. North America holds 49.8% of revenue, Type A products account for 98.8% of sales, and aesthetic use makes up 57.5%. Why the Botulinum Toxin Market Is Two Businesses in One The botulinum toxin market...